Author(s)

Céline Petit¹, Grégory Demolin¹, Athena Stamatiou², Samir Saadi³, Thierry Vandingenen⁴

¹Department of Obstetrics and Gynecology, CH Epicura, Hornu, Belgium.
²Department of Surgery, CH Epicura, Hornu, Belgium.
³Department of Pathological Anatomy, CH Epicura, Hornu, Belgium.
⁴Department of Medical Oncology CH Epicura, Hornu, Belgium.

Background: The incidence of cervical cancer in Belgium is 11.1 per 100,000. With the introduction of cervical cytology screening and more recently anti-HPV vaccination, this rate has been decreasing for almost 20 years. Despite this, some patients are missed by the screening and prevention system and cervical cancer is still diagnosed at an advanced stage. Recurrences by splenic metastases are rare and are most often found at autopsy. Case Study: We describe the case of a 41-year-old caucasian patient with a single splenic recurrence after radiotherapy, chemotherapy, brachytherapy, and surgery for a poorly differentiated adenocarcinoma of the cervix grade 3 at an initial stage IIB according to FIGO. This recurrence happens 3 years after the initial treatment. After monitoring this asymptomatic lesion, the size increase results in laparoscopic splenectomy. Histology demonstrates a splenic metastasis recurrence of adenocarcinoma of endocervical origin. Conclusion: The spleen is a rare metastatic site in cervical cancer. Splenectomy followed by chemotherapy is the therapy most often found in the literature, which is however poor in this regard.

Cervical Cancer, Recurrence, Splenic Metastasis, Human Papillomavirus

Petit, C. , Demolin, G. , Stamatiou, A. , Saadi, S. and Vandingenen, T. (2023) Recurrence of Poorly Differenciated Cervical Cancer by Single Splenic Metastasis: Case Report and Literature Review. Case Reports in Clinical Medicine, 12, 93-101. doi: 10.4236/crcm.2023.124013.